| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,762 |
8,204 |
$442K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
1,953 |
1,770 |
$304K |
| 99233 |
Prolong inpt eval add15 m |
4,998 |
1,567 |
$153K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
707 |
622 |
$111K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,145 |
1,937 |
$83K |
| 99223 |
Prolong inpt eval add15 m |
838 |
765 |
$70K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
883 |
850 |
$64K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,194 |
781 |
$56K |
| 99215 |
Prolong outpt/office vis |
944 |
897 |
$55K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
444 |
439 |
$55K |
| 87481 |
|
702 |
618 |
$45K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
792 |
733 |
$39K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
73 |
69 |
$39K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
694 |
611 |
$36K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
328 |
325 |
$35K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
471 |
391 |
$32K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
422 |
379 |
$21K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
383 |
286 |
$18K |
| 92250 |
|
259 |
254 |
$17K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
601 |
544 |
$16K |
| 76830 |
Ultrasound, transvaginal |
180 |
165 |
$15K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
186 |
66 |
$14K |
| 87529 |
|
487 |
462 |
$12K |
| 99220 |
|
141 |
136 |
$10K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
220 |
187 |
$10K |
| 92015 |
Determination of refractive state |
579 |
569 |
$9K |
| 87640 |
|
706 |
622 |
$9K |
| 87653 |
|
701 |
618 |
$9K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
212 |
200 |
$9K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
159 |
81 |
$9K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
486 |
460 |
$7K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
96 |
94 |
$7K |
| 87511 |
|
487 |
462 |
$6K |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
126 |
122 |
$5K |
| 81003 |
|
3,779 |
2,375 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
303 |
248 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
959 |
876 |
$4K |
| 99217 |
|
105 |
98 |
$4K |
| S0621 |
Routine ophthalmological examination including refraction; established patient |
73 |
72 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
56 |
43 |
$3K |
| 87563 |
|
161 |
147 |
$3K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
386 |
98 |
$3K |
| 59025 |
Fetal non-stress test |
81 |
43 |
$2K |
| 99245 |
|
16 |
16 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
163 |
148 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
162 |
147 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
40 |
25 |
$2K |
| 81025 |
|
360 |
336 |
$2K |
| 99225 |
|
56 |
38 |
$1K |
| 99254 |
|
14 |
14 |
$1K |
| 94760 |
|
5,309 |
4,784 |
$1K |
| 99255 |
|
12 |
12 |
$1K |
| 87500 |
|
79 |
68 |
$1K |
| 87641 |
|
79 |
68 |
$895.19 |
| S8301 |
Infection control supplies, not otherwise specified |
20 |
18 |
$485.50 |
| 93000 |
|
38 |
38 |
$354.94 |
| J3490 |
Unclassified drugs |
47 |
44 |
$334.60 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
29 |
28 |
$229.70 |
| 93041 |
|
43 |
41 |
$72.97 |
| 81001 |
|
16 |
13 |
$43.52 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
164 |
142 |
$26.39 |
| A4248 |
Chlorhexidine containing antiseptic, 1 ml |
107 |
97 |
$19.58 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
45 |
40 |
$16.12 |
| 80053 |
Comprehensive metabolic panel |
14 |
12 |
$12.17 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
776 |
512 |
$0.42 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
39 |
29 |
$0.31 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
5,299 |
4,763 |
$0.06 |
| 1036F |
|
763 |
563 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
320 |
282 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
4,565 |
4,146 |
$0.00 |
| 1111F |
|
381 |
326 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
43 |
39 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
347 |
314 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
108 |
94 |
$0.00 |
| 99459 |
|
397 |
350 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
17 |
12 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
8,460 |
7,413 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,643 |
1,412 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
496 |
348 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
243 |
210 |
$0.00 |
| 4004F |
|
268 |
262 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
696 |
666 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
197 |
176 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
63 |
60 |
$0.00 |
| G0029 |
Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period |
17 |
16 |
$0.00 |
| G8442 |
Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter |
13 |
13 |
$0.00 |
| 1159F |
|
12 |
12 |
$0.00 |
| 99490 |
Ccm add 20min |
12 |
12 |
$0.00 |